JNJ PG MRK PFE BMY Net Income R&D Expense

The net income and R&D expense data for Johnson & Johnson (JNJ), Procter & Gamble (PG), Merck (MRK), Pfizer (PFE), and Bristol-Myers Squibb (BMY) are as follows:

These figures demonstrate the financial strength and investment in innovation of these companies. The R&D expenses indicate their commitment to developing new products and advancing existing ones, while the net income reflects their overall profitability and the effectiveness of their business strategies.